Klug Emma, Solá-Del Valle David
Glaucoma Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.
Case Rep Ophthalmol. 2020 Jul 14;11(2):336-341. doi: 10.1159/000508391. eCollection 2020 May-Aug.
The purpose of the current case is to report the successful management of juvenile-onset open-angle glaucoma with bilateral XEN Gel Stent (Allegran Inc., Irvine, CA) implantation in a patient first diagnosed during pregnancy with co-existing dysautonomia. Treatment with the XEN Gel Stent provided dramatic reductions in intraocular pressure (IOP), and glaucoma medications sustained up to 23 months postoperatively. The success of this case may suggest that this minimally invasive procedure could be an effective treatment option for younger patients who require substantial reductions in IOP and glaucoma medication burden.
本病例报告的目的是介绍一名在孕期首次诊断为青少年型开角型青光眼且合并自主神经功能障碍的患者,通过双侧植入XEN凝胶支架(Allergan公司,加利福尼亚州欧文市)成功治疗的情况。XEN凝胶支架治疗使眼压(IOP)显著降低,青光眼药物治疗在术后持续了23个月。该病例的成功可能表明,这种微创手术对于需要大幅降低眼压和减轻青光眼药物负担的年轻患者可能是一种有效的治疗选择。